Skip to main content
Figure 1 | Journal of Biomedical Science

Figure 1

From: KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity

Figure 1

Chemical structure of KUD773 and identification of anti-proliferative effect. (A) Chemical structure of KUD773. (B) After the treatment with or without KUD773 for 48 h, the cells were fixed and stained with SRB and the data were analyzed. (C) PC-3 cells were labeled with CFSE and treated with vehicle or KUD773 (3 μM). The fluorescence intensity was determined by flow cytometric analysis. Data are expressed as mean ± SEM of three determinations. *P < 0.05 and **P < 0.01 compared with the respective control.

Back to article page